Next Article in Journal
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
Next Article in Special Issue
BUB3, beyond the Simple Role of Partner
Previous Article in Journal
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
Previous Article in Special Issue
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(5), 988; https://doi.org/10.3390/pharmaceutics14050988
Action Date Notes Link
article xml file uploaded 5 May 2022 11:19 CEST Original file -
article xml uploaded. 5 May 2022 11:19 CEST Update https://www.mdpi.com/1999-4923/14/5/988/xml
article pdf uploaded. 5 May 2022 11:20 CEST Version of Record https://www.mdpi.com/1999-4923/14/5/988/pdf
article supplementary file uploaded. 5 May 2022 11:20 CEST - https://www.mdpi.com/1999-4923/14/5/988#supplementary
article html file updated 5 May 2022 11:21 CEST Original file -
article html file updated 2 August 2022 22:15 CEST Update https://www.mdpi.com/1999-4923/14/5/988/html
Back to TopTop